1,3-Butadiene has been assessed as a Priority Substance under the Canadian Environmental Protection Act. The general population in Canada is exposed to
1,3-butadiene primarily through ambient air. Inhaled
1,3-butadiene is carcinogenic in both mice and rats, inducing
tumors at multiple sites at all concentrations tested in all identified studies. In addition,
1,3-butadiene is genotoxic in both somatic and germ cells of rodents. It also induces adverse effects in the reproductive organs of female mice at relatively low concentrations. The greater sensitivity in mice than in rats to induction of these effects by
1,3-butadiene is likely related to species differences in metabolism to active
epoxide metabolites. Exposure to
1,3-butadiene in the occupational environment has been associated with the induction of
leukemia; there is also some limited evidence that
1,3-butadiene is genotoxic in exposed workers. Therefore, in view of the weight of evidence of available epidemiological and toxicological data,
1,3-butadiene is considered highly likely to be carcinogenic, and likely to be genotoxic, in humans. Estimates of the potency of
butadiene to induce
cancer have been derived on the basis of both epidemiological investigation and bioassays in mice and rats. Potencies to induce ovarian effects have been estimated on the basis of studies in mice. Uncertainties have been delineated, and, while there are clear species differences in metabolism, estimates of potency to induce effects are considered justifiably conservative in view of the likely variability in metabolism across the population related to genetic polymorphism for
enzymes for the critical metabolic pathway.